Dr Reddy's to Conduct Phase 3 Trials of Russia's COVID Vaccine
Hyderabad-based pharma, Dr Reddy's, has signed an agreement with Russian Direct Investment Firm to conduct phase 3 trials of Sputnik V vaccine in India. According to the deal, Dr Reddy's will receive 100 million doses of the vaccine, which is expected to be available by the end of the year if the trials are successful. Last month, Russia had cleared the Sputnik V vaccine for public use.